I hold these stock.

DYOH (do your own homework.)

To-day there was a slight drop in price, but number of analysts are giving favourable reports.

What triggered my interest was better than expected results and if I am right looking at charts it shows an inverted head and shoulders. Hopefully a good sign. Also the current rate of Share price growth is about 90% pa over the last 5weeks. This is unlikely to continue indefinitely but SP could hit 850p over next few weeks.

To-day at close, there were some large buys of about 5million shares. 40million approx.

Another trigger for me was the following which should increase earnings.

Aviva to form JV in Taiwan with First FinancialAFX
LONDON (Thomson Financial) - Aviva PLC, the UK's largest insurer, said it has entered into a joint venture with First Financial Holding Co Ltd to sell insurance and pension products in Taiwan. The joint venture company, First-Aviva, will distribute long-term savings and pension products in Taiwan through an exclusive agreement with First Financial's flagship unit, First Commercial Bank. Aviva, which will have a 49 pct stake in the joint venture, added that the initial paid up capital of the new company will be 34 mln stg.First Commercial Bank is Taiwan's second largest bank network, with five mln retail customers, it added.TFN.newsdesk@thomson.comkkb/faj/slm




Date: Wednesday 25 Apr 2007
LONDON (ShareCast) - If the message gets home that Aviva will not bid for Prudential, the stock should rebound strongly, especially if Aviva can sustain its current impressive performance. There is still work to be done but, at 794.5p, the shares are a strong buy says the Independent.
Date: Tuesday 24 Apr 2007
LONDON (ShareCast) - Aviva stood out among the risers on a tough day for blue chip stocks. The life insurer posted an upbeat first quarter statement with brokers pleased with the numbers.



DYOH

thanks harry.

"Standard & Poor's maintained its "buy" recommendation and 505p target price for Aviva following the insurance group's approach from RSA to buy its general insurance operation in the UK, Ireland and Canada for 5 billion pounds, which was subsequently rejected. The broker finds it hard to envisage RSA, which has a market capitalisation of 4.3 billion pounds, being both willing and able to make a sufficiently attractive cash offer. Furthermore, the proposed transaction looks to be economically irrational from shareholders' point of view. A better way to do it, in S&P's opinion, would be to pool the target businesses of both Aviva and RSA in a 'newco', which it believes offers at least the same synergy benefits as an acquisition."

23rd Nov:
StockMarketWire.com
Aviva initiated with buy rating at Jefferies, target price 452p.

24th Nov:
StockMarketWire.com
Aviva downgraded to equal-weight from overweight at Morgan Stanley.

Anyone for 5 quid.

Interim Management Statement.

Part of the broker note from UBS:
"On track for full year
Q1 reported EV of 576p looks in line with the expected level for this time of year (FY10 542p) and on track for our full year forecast. The outlook comments are positive, particularly for general insurance, and the financial targets are reiterated. IGD surplus fell from 3.8bn to 3.5bn.
Valuation 470p PT based on Price/EV
The stock offers value on earnings (IFRS PER 9x, sector 12x, EEV PER 6x, sector 7x), but EPS dilution remains a risk until the group completes its disposals.
Price/EV 80% (sector 86%) and a yield of 6.2% (sector 4.8%) also suggest value.
We remain Neutral, however, as the next expected newsflow is further dilutive disposals."

Harry - I've had my current tranch from 383 - + 16p dividend paid today. I'm looking to sell - maybe even today - with a view to pick them up again. I hold them in a SIPP and over the last year, they have been fantastic (for me).

RNS Number : 9668I

Aviva PLC

23 June 2011

23 June 2011

AVIVA TO SELL RAC FOR GBP1 BILLION

-- Aviva to sell RAC to The Carlyle Group for GBP1.0 billion -- Price represents 17 times 2010 net earnings -- The sale is consistent with Aviva's strategic focus on insurance and savings businesses in its priority markets

Aviva plc ("Aviva") announces that it has agreed to sell RAC Limited ("RAC"), the second largest UK roadside assistance provider, to The Carlyle Group ("Carlyle") for GBP1.0 billion*. The transaction values RAC at 17 times 2010 net earnings**. Completion, which is subject to regulatory and competition approvals, is expected at the end of the third quarter of 2011.

Carlyle, a global alternative asset manager, with significant experience of investing in UK companies, is fully supportive of the RAC management team, led by RAC's Managing Director Angela Seymour-Jackson, and its strategy to profitably grow the business.

Andrew Moss, Group Chief Executive of Aviva, said:

"The sale of RAC is another important step for Aviva and realises significant value for our shareholders. Together with the recent partial disposal of Delta Lloyd, it demonstrates clear delivery of our strategy and provides the flexibility to deepen our presence in the priority markets where we have strength and scale."

Strategic rationale for the sale

The sale supports Aviva's strategy to focus on insurance and savings businesses in its priority markets and represents further significant progress in the transformation of Aviva's portfolio. The proceeds, which will be held as cash on the balance sheet, will enhance liquidity and further strengthen Aviva's balance sheet, enabling Aviva to continue to invest in its priority markets. In addition to the strategic benefits, Aviva remains confident in meeting the group's near-term financial targets.

Financial impact of the sale on Aviva

Based on 31 December 2010 results, this transaction will increase net assets by GBP0.6 billion and tangible net assets by GBP1.0 billion, or approximately 37p per share. Aviva's IGD surplus will improve by GBP0.2 billion. The accounting profit on disposal is expected to be GBP0.6 billion.

Aviva will retain the RAC (2003) pension scheme which at 31 December 2010 had an IAS19 deficit of approximately GBP160 million. On completion Aviva will make a one off contribution of GBP67 million into the scheme.

Future commercial relationship between Aviva and RAC

The sale of RAC is consistent with Aviva UK's strategy of maximising the benefits of operating life and general insurance together under one strong brand. Aviva will continue its commercial relationship with RAC both as a key underwriter of motor insurance on RAC's panel and as a partner, selling RAC breakdown cover to Aviva's customers. As RAC develops its business and extends its product offering both parties will seek to find new areas where they can work closely together.

J.P. Morgan Cazenove acted as sole financial adviser to Aviva.

Limited out of these @439 so flat for now.

Back in @424.46p

Back in the money here.

rumours of a 6 a share take over doing the rounds.... fingers crossed

Yes the rumours started yesterday in the Guardian - hence the spike this morning. It would be nice but........

No chance, imo.

Harry - I was tempted to sell in the 440 area again this morning, but held fire - whatever else, this and possibly NG, is probaly been my best SIPP investment over the last year.

Nice one skinny!
On the subject of AV., having sold the RAC and focussed their strategy on specific insurance/pension risks, I would be very surprised if they are taken over. They are now a global brand (having dropped the Norwich Union tag) and I would suspect they are on the acquisition trail themselves, possibly in emerging markets. Press boredom and pressure to produce a story, imo.

I think you are probably right - but a little bit of me hopes - hence I'll hold for now :-)

StockMarketWire.com
Insurance giant Aviva this morning reported a strong performance with total operating profit up 5% to 1.337bn in the half-year to end-June (2010: 1.27bn).

Operating profits in Europe were up 21% to 525m despite financial and economic difficulties in the eurozone.

Operating earnings per share increased to 29.1p, although total earnings per share of 4.1p are lower primarily as a result of unrealised Delta Lloyd investment variances.

Pro forma MCEV NAV, including the impact of the sale of RAC, was up 33p from 2010 to 575p per share.

Group return on equity was strong at 12.8% (FY10: 14.8% on a lower equity base).

There was a 5% increase in interim dividend to 10p. Aviva reported a 14% life insurance new business internal rate of return (IRR), against a target of 12%.

There was a 96% group combined operating ratio (COR), against a target of 97%.

The group saw 0.8bn net operational capital generation in H1 towards the 1.5bn full-year target; now targeting between 1.5bn and 1.8bn in 2011.

Aviva said it was on track to deliver 400m cost and efficiency savings by 2012. The group said the sale of RAC at 17x earnings for 1bn will realise significant shareholder value.

Reduced shareholding and deconsolidation of Delta Lloyd will raise 0.4bn and further de-risking the balance sheet.

The pro forma economic capital surplus, including the impact of the sale of the RAC, was up 23% at 6.9bn (2010: 5.6bn). Andrew Moss, CEO, commented: "This has been a successful six months. We are beating all our operational targets. Operating profits rose in the UK and have increased by 21% in Europe despite tough economic conditions.

"After recent disposals, Aviva is fitter, stronger and well-positioned to be the undisputed leader in the UK market and to build on our strong European franchises.

"Markets may well continue to be volatile, but our strong balance sheet and capital position underpins our confidence in our continued momentum and our plans for growth."

RNS Number : 1890M

Aviva PLC

11 August 2011

11 August 2011

AVIVA ANNOUNCES SALE OF AVIVA INVESTORS' EQUITY BUSINESS IN AUSTRALIA

Aviva today announces the sale of Aviva Investors Australia Ltd ("AIAL") to nabInvest, National Australia Bank's direct asset management business.

The sale is consistent with Aviva Investors' strategy to focus on growing its Asian regional hub in Singapore, and consistent with Aviva group's strategy to focus on 12 priority markets.

The transaction, which is subject to regulatory approval, is expected to close in the third quarter of 2011.

AIAL had IFRS gross assets of A$32 million at 31 December 2010 and assets under management of approximately A$5.5 billion at 31 July 2011.

Sp approaching 2 year low of trading range 300-450p.
Employees share option price is currently 268p.
Also, ex-divi 21st Sept '11, 10p.